Antibiotic Susceptibility of Multi-drug resistant Mycobacterium tuberculosis using Flow Cytometry

Increased resistance of Mycobacterium tuberculosis (M. tuberculosis) to antibiotics has emphasized the need for rapid susceptibility testing. BACTEC MGIT 960 system is routinely used for drug susceptibility testing; however, the main drawback is the long incubation time. An alternative flow cytometry-based assay was evaluated for the assessment of drug susceptibility. Thirteen multi-drug resistant (MDR) M. tuberculosis cultures were tested against rifampicin (1 μg/ml), isoniazid (0.2 μg/ml), ethambutol (7.5 μg/ml), and ofloxacin (2 μg/ml) using flow cytometry by staining cells with SYTO16 and propidium iodide. Correlation rates of flow cytometry results with BACTEC MGIT 960 system were 28.5% (rifampicin); 15.4% (isoniazid), 61.5% (ethambutol) and 46.1% (ofloxacin). Findings indicate that while flow cytometry for tuberculosis (TB) drug susceptibility may reduce the length of time taken for diagnosis, there was low correlation with BACTEC MGIT 960. The high cost associated with implementation of the technique in diagnostic laboratories is a further disadvantage. Further studies with larger sample sizes are needed to confirm these data.

[1]  Kemin Wang,et al.  Using fluorescent nanoparticles and SYBR Green I based two-color flow cytometry to determine Mycobacterium tuberculosis avoiding false positives. , 2008, Biosensors & bioelectronics.

[2]  S. Sethi,et al.  Susceptibility testing of Mycobacterium tuberculosis by broth microdilution method: a rapid alternative method. , 2007, Diagnostic microbiology and infectious disease.

[3]  R. Schell,et al.  Rapid pyrazinamide susceptibility testing of Mycobacterium tuberculosis by flow cytometry. , 2006, Journal of microbiological methods.

[4]  P. V. van Helden,et al.  Safe Mycobacterium tuberculosis DNA Extraction Method That Does Not Compromise Integrity , 2006, Journal of Clinical Microbiology.

[5]  Y. Akselband,et al.  Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry. , 2005, Journal of microbiological methods.

[6]  R. Schell,et al.  Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  M. Lourenço,et al.  Comparison of Flow Cytometric and Alamar Blue Tests with the Proportional Method for Testing Susceptibility of Mycobacterium tuberculosis to Rifampin and Isoniazid , 2004, Journal of Clinical Microbiology.

[8]  S. Kirk,et al.  Safe Determination of Susceptibility of Mycobacterium tuberculosis to Antimycobacterial Agents by Flow Cytometry , 1999, Journal of Clinical Microbiology.

[9]  S. Kirk,et al.  Flow cytometric testing of susceptibilities of Mycobacterium tuberculosis isolates to ethambutol, isoniazid, and rifampin in 24 hours. , 1999, Journal of clinical microbiology.

[10]  M. Poot,et al.  Bacterial viability and antibiotic susceptibility testing with SYTOX green nucleic acid stain , 1997, Applied and environmental microbiology.

[11]  S. Sullivan,et al.  Rapid assay for mycobacterial growth and antibiotic susceptibility using gel microdrop encapsulation , 1995, Journal of clinical microbiology.

[12]  R. Schell,et al.  Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry , 1995, Journal of clinical microbiology.

[13]  E. Engleman,et al.  Discrimination of viable and non-viable cells using propidium iodide in two color immunofluorescence. , 1987, Cytometry.

[14]  S. Costa-de-Oliveira,et al.  Safe susceptibility testing of Mycobacterium tuberculosis by flow cytometry with the fluorescent nucleic acid stain SYTO 16. , 2005, Journal of medical microbiology.

[15]  D. Mitchison,et al.  The curious characteristics of pyrazinamide: a review. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.